ArticleWorld journal of microbiology & biotechnology2026
Semi-rational design of the N-terminal of Chondroitinase ABC to improve the catalytic activity.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chondroitinase ABC (ChSase ABC), which can digest chondroitin sulfate (CS), has been utilized for the analysis of CS glycan structure and the preparation of low-molecular-weight chondroitin sulfate. However, the catalytic activity of most ChSase ABCs remains insufficient for industrial or large-scale applications. Previous structure studies of ChSase ABCs indicate that the N-terminal domain is typically involved in substrate recognition and binding. Furthermore, the N-terminal domain of the ChSase ABC from Bacteroides thetaiotaomicron (BtChSase ABC) also exhibits similarity with the carbohydrate-binding module of other glycosidases. In the present work, the N-terminal of BtChSase ABC was chosen for engineering. Through multiple sequence alignment, 9 non-conserved residues were selected as candidate mutation sites, and a mutant library containing 20 variants was constructed by single-point and combinatorial mutations. Among them, the catalytic activity of 13 mutants showed varying degrees of improvement. The mutant L137V showed 79.29% and 84.49% increases in specific activity and Vmax, respectively, compared to the wild type. SAX-HPLC analysis of enzymatic hydrolysates confirmed that the mutation retained the enzyme’s substrate recognition and cleavage mechanism. Kinetic parameters revealed that the enhanced catalytic activity of the mutants was mainly attributed to an increased turnover number (kcat), indicating that the rate-limiting step of catalysis was effectively accelerated.
Indexed as
Identifiers
41998444What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.